Sünnet sonrasında gelişen methemoglobinemi olgusu ve tedavisi

Methemoglobinemi, özellikle lidokain ve prilokain kullanılan durumlarda gözlenen, klinik olarak ağır seyreden bir durumdur. Prilokain, infiltrasyon anestezisinde kısa etki profilinden dolayı en sık kullanılan amid tipi lokal anesteziklerden biri olup, ayrıca edinsel methemoglobinemiye en sık neden olan ajanlardan biridir.Olgumuzda 2 ay 10 günlük çocuğa dorsal penil blokaj ile yapılan sünnet sonucunda görülen methemoglobineminin yönetiminden sunacağız

Anahtar Kelimeler:

Methemoglobinemi, prilokain, sünnet

Methemoglobinemia developing after circumcision and its treatment

Methemoglobinemia, especially observed in cases used lidocaine and prilocaine, is a condition characterized severe clinical. Prilocaine, is one of the most commonly used amide-type local anesthetics in infiltration anesthesia, is also one of the most common causative agent of acquired methemoglobinemia.In our case, 2 months 10 days of the child, we will provide management of methemoglobinemia as a results of circumcision with dorsal penile block

Keywords:

circumcision, methemoglobinemia, prilocaine,

PDF

___

Morgan GE, Mikhail MS, Murray MJ. Clinical Anesthesio- logy, Third edition 2002; 233-308.
Lipkind GM, Fozzard HA. Molecular Modeling of Local Anesthetic Drug Binding by Voltage-Gated Sodium Chan- nels. Mol Pharmacol 2005; 68: 1611-22.
Cousins MJ, Bridenbaugh PO. Neural Blockade In Clini- cal Anesthesia and Management of Pain. Lippincott-Raven 1998; 55-95.
Naguib M, Magboul MM, Samarkandi AH, Attia M. Ad- verse effects and drug interactions associated with local and regional anaesthesia. Drug Saf 1998;18:221-50.
Rehman HU. Methemoglobinemia. West J Med 2001; 175: 93-196.
Maimo G, Redick E. Dimens Crit Care Nurs 2004; 23(3): 116-8.
Kara A, Yiğit Ş, Aygün C, Oran O. Toxic methemoglobine- mia after injection of prilocaine in a newborn. Turk J Pedi- atr 1998; 40: 589-92.
Moore TJ, Walsh CS, Cohen MR. Arch Intern Med 2004; 164: 1192-6.
Guay J. Anesth Analg 2009; 108: 837-45.
Rodriguez LF, Smolik LM, Zbehlik AJ. Ann Pharmacother 1994; 28: 643-9.
Waller HD, Benohr HC, Tigges FJ. Zum mechanismus der methamoglobinreduktion in menschlichen erythrozyten durch ascorbinsaure. Klinische Wochenschrift 1977; 55: 955-964.
Honig GR. Hemoglobin disorder. In: Behrman RE, Kleig- man RM, Jenson HB (eds). Nelson Textbook of Pediatrics. Philadelpiha: Saunders 2000: 1478-1488.
Mansouri A. Methemoglobinemia. Am J Med Sci 1985; 289: 200-9.
Liao YP, Hung DZ, Yang DY. Hemolytic anemia after meth- ylene blue therapy for aniline-induced methemoglobine- mia. Vet Hum Toxicol 2002; 44: 19-21.
Sinisterra S, Miravet E, Alfonso I, Soliz A, Papazian O. Methemoglobinemia in an infant receiving nitric oxide af- ter the use of eutectic mixture of local anesthetic. J Pediatr 2002; 141: 285-6.
Hahn IH, Hoffman RS, Nelson LS. EMLA-induced met- hemoglobinemia and systemic topical anesthetic toxicity. J Emerg Med 2004; 26: 85-9.
Türkmen E, Kocabay G, Yavuz S, et al. Case of methemog- lobinemia induced by the administration of prilokain prior to an epilation. J İst Faculty Med 2005; 68: 19-21.
Kızılyıldız BS, Sönmez B, Karaman K, Caksen H. Toxic methemoglobinemia due to prilocaine use. J Emerg Med 2010; 38: 663-4.
Gülgün M, Kul M, Sarıcı SÜ, Alpay F. Prilocine-induced methenoglobinemia: report of two cases and review of lite- rature. Erciyes Medical Journal 2007; 29: 322-5.
Caner İ, Ziraatçi Ö, Taştekin A. Oral Metilen Mavisi ile Te- davi Edilen Prilokaine Bağlı Bir Methemoglobinemi Olgu- su. Türkiye Çocuk Hast Derg 2011; 5: 172-6.
Svecova D, Bohmer D. Congenital and acquired methe- moglobinemia and its therapy. Cas Lek Cesk 1998; 137: 168-70.